MedPath

Examination of the efficacy of the high gamma PGA natto on the suppression of postprandial glucose elevation by single-dose test.

Not Applicable
Conditions
Healthy subjects
Registration Number
JPRN-UMIN000030182
Lead Sponsor
Course of clinical research and regional innovation donated by the Japan Agriculture Ibaraki Public Welfare Federation Fuculty of Medicine University of Tsukuba
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1. Subjects who are treated for diabetes. 2. Subjects who are taking medications for dislipidemia, hypertention, and anemia. 3. Subjects who are taking warfarin. 4. Subjects who are habitually taking medication and/or supplement (including "food for specified health use", and "foods with function claims") that affect glucose metabolism. 5.Subjects who are diagnosed for anemia or have treatment history for anemia. 6. Subjects who are enrollment in another interventional study 7. Subjects who were recognized unsuitable for this study by the Investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath